Italia markets closed

JNJ Jul 2024 150.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,5000-1,0500 (-18,92%)
In data: 02:49PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente5,5500
Aperto5,5900
Denaro4,0000
Domanda4,6000
Prezzo d'esercizio150,00
Scadenza2024-07-19
Min-Max giorno4,3000 - 5,6700
Contratto - Min-MaxN/D
Volume627
Open Interest6,43k
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA